| （単位：千ドル） | 1Q20 | 2Q20 | 3Q20 | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | - | - | - | - | - | 7,188 | 8,188 | 8,135 | 9,022 | 9,805 | 13,297 | 14,848 | 10,298 | 11,296 | 14,455 | 16,157 |
| 営業費用 | - | - | - | - | - | 10,079 | 12,778 | 11,963 | 12,708 | 13,947 | 17,827 | 19,362 | 15,072 | 15,993 | 19,889 | 21,802 |
| 営業利益 | -229 | -328 | -221 | -215 | -563 | -10,079 | -12,778 | -11,963 | -12,708 | -13,947 | -17,827 | -19,362 | -15,072 | -15,993 | -19,889 | -21,802 |
| 経常（税引前）利益 | 96 | -284 | -210 | 5,498 | -3,570 | - | - | - | - | - | - | - | - | - | - | - |
| 法人税等合計 | 57 | -2 | -9 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 実効税率（％） | - | - | - | - | - | - | - | - | - | - | - | - | - | |||
| 純利益 | 38 | -283 | -202 | 5,498 | -3,570 | - | -2,207 | -10,404 | -11,863 | -14,260 | -16,080 | -17,544 | -13,700 | -14,583 | -18,637 | -21,200 |
| 一株あたり利益 | - | - | - | - | - | - | - | - | -0.32 | -0.16 | -0.15 | -0.16 | -1.03 | -0.97 | -1.24 | -1.41 |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | - | - | -0.32 | -0.16 | -0.15 | -0.16 | -1.03 | -0.97 | -1.24 | -1.41 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | -19,062 | - | - | - | - |